Head-to-head review: Know Labs (KNWN) versus its peers

0

Know Labs (OTCMKTS:KNWN – Get Rating) is one of 28 public companies in the “Measurement and Control Devices, Not Elsewhere Classified” industry, but how does it compare to competitors? We will compare Know Labs to similar companies based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, risk and earnings.

Benefits and evaluation

This chart compares the gross revenue, earnings per share, and valuation of Know Labs and its competitors.

Gross revenue Net revenue Price/earnings ratio
Know the laboratories $120,000.00 -$25.36 million -1.89
Know Labs Competitors $2.66 billion $435.24 million 11.10

Know Labs competitors have higher revenue and profit than Know Labs. Know Labs trades at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Know Labs has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500. By comparison, Know Labs’ competitors have a beta of 1.03, suggesting that their stock price average is 3% more volatile than the S&P 500. .

Analyst Recommendations

This is a summary of recent ratings and recommendations for Know Labs and its competitors, as provided by MarketBeat.com.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Know the laboratories 0 0 1 0 3.00
Know Labs Competitors 154 689 953 28 2.47

Know Labs currently has a consensus price target of $7.00, suggesting a potential upside of 363.58%. As a group, the “Measuring and Control Devices, Not Elsewhere Classified” companies have an upside potential of 29.09%. Given Know Labs’ higher consensus rating and higher possible upside, stock analysts clearly believe Know Labs is more favorable than its competitors.

Profitability

This table compares the net margins, return on equity, and return on assets of Know Labs and its competitors.

Net margins Return on equity return on assets
Know the laboratories N / A -968.13% -192.31%
Know Labs Competitors -3,288.70% 4.83% 1.80%

Insider and Institutional Ownership

10.6% of Know Labs shares are held by institutional investors. In comparison, 61.0% of the shares of all “Measurement and control devices, not elsewhere classified” companies are held by institutional investors. 44.0% of Know Labs stock is held by company insiders. By comparison, 16.1% of the shares of all “Measurement and Control Devices, Not Elsewhere Classified” companies are held by insiders of the company. Strong institutional ownership indicates that endowments, hedge funds, and large fund managers believe a stock will outperform the market over the long term.

Summary

Know Labs competitors beat Know Labs on 7 of the 13 factors compared.

About Know Labs (Get a rating)

Know Labs, Inc. is focused on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. Bio-RFID technology can be integrated into a variety of portable, mobile, or benchtop form factors. Its first application of Bio-RFID technology is in a product marketed as a glucose monitor that provides the user with real-time information about their blood sugar levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.



Get news and reviews for Know Labs Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Know Labs and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.